Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol
- 31 January 1988
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 15, 43-48
- https://doi.org/10.1016/0305-7372(88)90073-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.Journal of Clinical Oncology, 1986
- The role of recombinant interferon alfa-2a in the therapy of cutaneous t-cell lymphomasCancer, 1986
- Treatment of multiple myeloma with recombinant interferon alfa-2aCancer, 1986
- Treatment of multiple myeloma with recombinant alpha-interferonBlood, 1986
- Treatment of multiple myeloma: A randomized study of three different regimensLeukemia Research, 1985
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assayCancer Chemotherapy and Pharmacology, 1983
- Effects of cloned human leukocyte interferons in the human tumor stem cell assay.Journal of Clinical Oncology, 1983
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979